In nominating Jens Frahm, the European Patent Office is honoring his breakthrough developments in magnetic resonance imaging (MRI). In two steps, the scientist and his team succeeded in speeding up MRI by a factor of up to 10,000: FLASH MRI, which has become one of the most important clinical imaging methods worldwide, was developed in the mid-1980s. Then, in 2010, the researchers in Göttingen achieved a breakthrough to real-time MRI with the FLASH2 method. FLASH2 makes it possible for the first time to film processes inside the body in real time.
Does a patient have brain tissue abnormalities? Have an accident victim’s internal organs been damaged? Is there a herniated disc? Is a patient’s heart function impaired? To answer such questions, radiologists turn to MRI – and FLASH technology. MRI rapidly delivers precise cross-sectional and even three-dimensional images of the body. The technique is particularly good at detecting pathological changes in virtually all organs of the body. Unlike X-ray methods, such as computed axial tomography (CAT scans), it is also completely safe for patients.
MRI exploits a special property of hydrogen nuclei, which are ubiquitous in the body: their angular momentum, also known as nuclear spin. Nuclear spin makes the atomic nuclei act like tiny magnets. When exposed to a magnetic field, they align themselves along the magnetic lines of force. An MRI scanner generates this type of magnetic field as well as short radio pulses in the VHF range, which temporarily nudge the nuclear spins out of their normal equilibrium state. As they return to their original orientation, they emit radio waves that are then detected by highly sensitive coils. After many repetitions, the location-dependent signals generated can be used to compute an image that accurately captures details of organs and vessels.
100 million scans a year with FLASH
Frahm’s technology revolutionized MRI around twelve years after its invention by Paul Lauterbur in 1973 by greatly speeding up the process. Until then, MRI had a serious drawback: For being used in clinical diagnostics, it was simply too slow, with a single cross-sectional image taking several minutes to capture. This was due to the large number of measurements with different spatial encodings needed and the necessary pauses between them. “Our idea in the 1980s was to use only part of the available MRI signal for each measurement. This physical trick allowed us to eliminate the pauses completely and to dramatically shorten the measuring times by a factor of at least a hundred,” Frahm explains. Today, around 100 million MRI scans are performed every year – all taking advantage of Frahm’s technology. FLASH is the Max Planck Society’s most successful patent to date and it has helped MRI to achieve a breakthrough in medical diagnostics.
Live video of the beating heart
In 2010, Frahm and his team finally solved the problem of needing a large number of individual measurements. To put it simply, FLASH2 is FLASH with video speed. It uses a new mathematical algorithm for reconstructing images from only very few measurements with different spatial encodings. The technique again significantly increases the speed of MRI scans and can capture up to 100 images per second.
FLASH2 brings MRI to life as it renders processes within the body visible – a landmark advance for medical diagnostics. For the first time, it is possible to directly observe joint movements, speech and swallowing processes as well as the beating heart in real time. It further allows to draw conclusions, for example, about why a patient experiences knee pain, has heartburn, stutters, or has chest pain. The new technique could also potentially be used as an aid in minimally invasive surgery and other interventions that, until now, have been performed under X-ray control. Real-time MRI is currently being tested for routine use on patients at the University Medical Center Göttingen and at several other universities in Germany, the UK, and the United States.
About the European Inventor Award
The European Inventor Award, a prestigious prize for innovation in Europe, will be presented for the 13th time in 2018. It has been awarded annually by the European Patent Office since 2006. To qualify for the prize, submitted proposals must meet specific criteria, such as proof that the European Patent Office has granted at least one patent for the invention.
A high-calibre international jury from the worlds of industry, politics, science, and research then reviews the extent to which the nominated inventors have contributed to technical and social progress, prosperity, and the creation of jobs in Europe.
About Jens Frahm
Jens Frahm studied physics at the University of Göttingen and carried out research for his PhD in physical chemistry at the MPI for Biophysical Chemistry. He then worked as a scientific assistant at the same institute, where he headed the independent Biomedical NMR research group from 1982 to 1992. Frahm has been director at the Biomedizinische NMR Forschungs GmbH, a non-profit organization set up within the institute, since 1993. He habilitated at the University of Göttingen in 1994 and became adjunct professor at the university’s chemistry department in 1997. Jens Frahm is listed as the inventor of four European patents.
Jens Frahm has received many prizes for his research work, including the European MRI Award of the Deutsche Röntgengesellschaft (1989), the Gold Medal Award of the International Society for Magnetic Resonance in Medicine (1991), the Karl Heinz Beckurts Award (1993), the Research Award of the Sobek Foundation (2005), the Stifterverband Award (2013), and the Jacob Henle Medal (2016). Jens Frahm was elected into the Hall of Fame of German Science in 2016.
Prof. Dr. Jens Frahm, Head of Biomedical NMR
Max Planck Institute for Biophysical Chemistry, Göttingen
Dr. Carmen Rotte, Head of public relations
Max Planck Institute for Biophysical Chemistry, Göttingen
phone: +49 551 201-1304